Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases

被引：6
|
作者：
Sengler, C. [1 ]
Niewerth, M. [1 ]
Kallinich, T. [2 ]
Nimtz-Talaska, A.
Haller, M.
Huppertz, H. -I. [3 ]
Minden, K. [1 ]
机构：
[1] German Rheumatism Res Ctr Berlin, Leibniz Inst, Epidemiol Unit, D-10117 Berlin, Germany
[2] Charite, Childrens Univ Hosp, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany
[3] Klinikum Bremen Mitte, Bremen, Germany
来源：
CLINICAL RHEUMATOLOGY | 2014年 / 33卷 / 01期
关键词：
Children; Disease activity; Flare; H1N1 influenza vaccination; Rheumatic disease; JUVENILE IDIOPATHIC ARTHRITIS; SAFETY; IMMUNOGENICITY;
D O I：
10.1007/s10067-013-2435-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The objective of this study is to evaluate complications and changes in health status (disease activity and flare) in response to the AS03-adjuvanted H1N1 vaccine in children with rheumatic diseases. We conducted a nationwide survey addressing paediatric rheumatology sites who participated in the national paediatric rheumatology database. Ninety patients were documented-38 % under treatment with biologicals-of whom 18 % suffered from complications (10 % local and 8 % systemic) with no relevant changes in median disease activity or flare rate during 4 weeks following the vaccination. The adjuvanted H1N1 influenza vaccine seems to be adequately tolerated in children with rheumatic diseases.
引用
收藏
页码：137 / 139
页数：3
相关论文
共 50 条
  • [31] Risk of Narcolepsy Associated with Inactivated Adjuvanted (AS03) A/H1N1 (2009) Pandemic Influenza Vaccine in Quebec
    Montplaisir, Jacques
    Petit, Dominique
    Quinn, Marie-Josee
    Ouakki, Manale
    Deceuninck, Genevieve
    Desautels, Alex
    Mignot, Emmanuel
    De Wals, Philippe
    PLOS ONE, 2014, 9 (09):
  • [32] Immunogenicity and safety of a novel AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in adults in Japan
    Ikematsu, Hideyuki
    Nagai, Hideaki
    Kawashima, Masahiro
    Kawakami, Yasunobu
    Tenjinbaru, Kazuyoshi
    Maeda, Atsushi
    Li, Ping
    Gillard, Paul
    Roman, Francois
    HUMAN VACCINES, 2010, 6 (11): : 888 - 893
  • [33] Adjuvanted or whole-virion vaccine for 2009 influenza A (H1N1)
    Barrett, P. Noel
    Ehrlich, Hartmut J.
    LANCET INFECTIOUS DISEASES, 2011, 11 (07): : 496 - 497
  • [34] Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis
    Miller, Elizabeth
    Andrews, Nick
    Stellitano, Lesley
    Stowe, Julia
    Marie, Anne
    Shneerson, John
    Verity, Christopher
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [35] Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1/2009 vaccine in young autoimmune rheumatic diseases patients
    Aikawa, N. E.
    Trudes, G.
    Campos, L. M. A.
    Pereira, R. M. R.
    Moraes, J. C. B.
    Ribeiro, A. C.
    Miraglia, J.
    Timenetsky, M. do Carmo S.
    Bonfa, E.
    Silva, C. A.
    LUPUS, 2013, 22 (13) : 1394 - 1398
  • [36] Safety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort study (vol 3, e001912, 2013)
    Nazareth, I
    Tavares, F.
    Rosillon, D.
    BMJ OPEN, 2013, 3 (02):
  • [37] Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children
    Ortqvist, Ake
    Bennet, Rutger
    Hamrin, Johan
    Rinder, Malin Ryd
    Lindblad, Hans
    Ohd, Joanna Nederby
    Eriksson, Margareta
    VACCINE, 2015, 33 (22) : 2558 - 2561
  • [38] Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trial
    Yang, William H.
    Dionne, Marc
    Kyle, Michael
    Aggarwal, Naresh
    Li, Ping
    Madariaga, Miguel
    Godeaux, Olivier
    Vaughn, David W.
    VACCINE, 2013, 31 (40) : 4389 - 4397
  • [39] Immunogenicity and Efficacy in Hemodialysis Patients of an AS03A-Adjuvanted Vaccine for 2009 Pandemic Influenza A(H1N1): A Nonrandomized Trial
    Dikow, Ralf
    Eckerle, Isabella
    Ksoll-Rudek, Dorothea
    Hampel, Heidrun
    Schwenger, Vedat
    Zeier, Martin
    Schnitzler, Paul
    Sommerer, Claudia
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (05) : 716 - 723
  • [40] Safety and immunogenicity of 2010-2011 A/H1N1pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine Results of a randomized trial
    Scheifele, David W.
    Dionne, Marc
    Ward, Brian J.
    Cooper, Curtis
    Vanderkooi, Otto G.
    Li, Yan
    Halperin, Scott A.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (01) : 136 - 143
12345